Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low‐density lipoprotein receptor knockout mice
Author:
Affiliation:
1. Department of Pharmacy, Integrated Research Institute of Pharmaceutical Sciences, and BK21 PLUS Team for Creative Leader Program for Pharmacomics‐based Future Pharmacy, College of Pharmacy The Catholic University of Korea Bucheon‐si Korea
Funder
Catholic University of Korea
National Research Foundation
Publisher
Wiley
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1755-5922.12476
Reference37 articles.
1. Atherosclerosis — An Inflammatory Disease
2. Is atherosclerosis an immunologically mediated disease?
3. Evidence for a role of tumor necrosis factor α in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease
4. Anti-TNF therapy: past, present and future
5. Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cilostazol may be a better therapeutic agent for acute ischemic stroke because of its efficacy in preventing post-stroke depression;2023-10-31
2. Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice;In Vivo;2023
3. Topical application of Porphyromonas gingivalis into the gingival pocket in mice leads to chronic‑active infection, periodontitis and systemic inflammation;International Journal of Molecular Medicine;2022-06-15
4. A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice;Bleeding, Thrombosis, and Vascular Biology;2022-05-23
5. Cilostazol attenuates cardiac oxidative stress and inflammation in hypercholesterolemic rats;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-04-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3